Nymox Pharmaceutical
NYMX
#9275
Rank
A$27.37 M
Marketcap
Bahamas
Country
$0.30
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

EPS for Nymox Pharmaceutical (NYMX)

EPS in 2023 (TTM): -$0.09066

According to Nymox Pharmaceutical's latest financial reports the company's current EPS (TTM) is -$0.08999. In 2022 the company made an earnings per share (EPS) of -$0.12 an increase over its 2021 EPS that were of -$0.22.

EPS history for Nymox Pharmaceutical from 1997 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$0.09066-24.45%
2022-$0.12-46.67%
2021-$0.22-11.76%
2020-$0.25-15%
2019-$0.305.26%
2018-$0.28-26.92%
2017-$0.39-7.14%
2016-$0.42-40.43%
2015-$0.70291.67%
2014-$0.18-7.69%
2013-$0.19-43.48%
2012-$0.34-25.81%
2011-$0.4655%
2010-$0.3025%
2009-$0.240.08%
2008-$0.24-11.12%
2007-$0.27-0.16%
2006-$0.2728.59%
2005-$0.21-12.49%
2004-$0.24-16.05%
2003-$0.2919.07%
2002-$0.2414.45%
2001-$0.21-22.16%
2000-$0.275.64%
1999-$0.26-34.59%
1998-$0.39-3.6%
1997-$0.40

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$4.46-5,053.67%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.79-3,200.00%๐Ÿ‡บ๐Ÿ‡ธ USA
$10.14-11,366.67%๐Ÿ‡บ๐Ÿ‡ธ USA
$8.14-9,148.82%๐Ÿ‡บ๐Ÿ‡ธ USA
$21.13-23,575.50%๐Ÿ‡บ๐Ÿ‡ธ USA